Skip to main content
. Author manuscript; available in PMC: 2014 Mar 29.
Published in final edited form as: Nat Rev Mol Cell Biol. 2012 Jan 23;13(2):115–126. doi: 10.1038/nrm3274

Table 2.

H3K36 methyltransferases and their roles in diseases

Gene Diseases Molecular defects Phenotypes Refs
NSD1 Sotos syndrome Haploinsufficiency, point mutations, deletions, translocations Macrocephaly, hypertolerism, cognitive and/or motor skill deficiencies 98
NSD1 Myelodysplastic syndrome Translocations Anaemia, cytopenia 111
NSD1 Cancers: AML, prostate, neuroblastoma, breast Overexpression, gene silencing, translocations Numerous tumour types 19,78,101, 110,112
NSD2 Wolf–Hirschhorn syndrome Deletions Learning difficulties, microcephaly, heart defects 32
NSD2 Multiple myeloma t(4;14)+ translocation Renal failure, anaemia, bone lesions 30,115
NSD3 Breast cancer Gene amplification at 8p11 Solid tumours 107
NSD3 AML Translocations Leukaemic cells in bone marrow 105
NSD3 Myelodysplastic syndrome Translocations Anaemia, cytopenia 106
SETD2 Renal cell carcinoma Deletions, missense mutations Haematuria, flank pain 99

The table lists the known diseases resulting from alterations in the genes encoding enzymes that are specific for Lys36 on histone H3 (H3K36). AML, acute myeloid leukaemia; NSD, nuclear receptor SET domain-containing; SETD2, SET domain-containing 2.